手法を比較
選択した手法を並べて確認できます。異なる行はハイライト表示されます。
| 異種間薬物動態スケーリング× | 生理学的基礎薬物動態学× | |
|---|---|---|
| 分野 | 薬理学 | 薬理学 |
| 系統 | Process / pipeline | Process / pipeline |
| 提唱年≠ | 1989 | 1997 |
| 提唱者≠ | John Mordenti | Ivan Nestorov |
| 種類≠ | inter-species extrapolation | predictive modeling |
| 原典≠ | Mordenti, J., & Chappell, W. (1989). The use of allometric scaling in toxicokinetic studies. Fundamental and Applied Toxicology, 13(2), 335-346. link ↗ | Nestorov, I. (1997). Sensitivity analysis of pharmacokinetic and pharmacodynamic systems. Journal of Pharmacokinetics and Biopharmaceutics, 25(4), 529-543. link ↗ |
| 別名≠ | allometric scaling, inter-species extrapolation, FIH dose prediction | PBPK, PBPK modeling |
| 関連 | 3 | 3 |
| 概要≠ | Allometric scaling is a mathematical approach for predicting human pharmacokinetics from preclinical animal data using body weight relationships. Developed systematically by Mordenti and colleagues in the late 1980s, it enables rational first-in-human dose prediction without assuming species-specific metabolic differences. | PBPK is a mechanistic modeling framework that uses physiological parameters, tissue properties, and drug-specific attributes to predict drug concentration time profiles in the body. Developed rigorously in the 1990s by researchers including Nestorov, PBPK integrates anatomy, biochemistry, and kinetics to enable rational drug development, bridging in vitro data to clinical outcomes. |
| ScholarGateデータセット ↗ |
|
|